1 / 2

Supplementary Figure 1

Supplementary Figure 1. A. B. #1 #2 #3. Group 1. #4 #5 #6. CD20. Group 2. C. #7 #8 #9. Group 3. MHC I. Her-2/ neu.

odell
Télécharger la présentation

Supplementary Figure 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figure 1 A B #1 #2 #3 Group 1 #4 #5 #6 CD20 Group 2 C #7 #8 #9 Group 3 MHC I Her-2/neu

  2. Supplementary Figure 1. Confirmation of Her-2/neu expression on autologous B lymphoblastoid cells (BLCL) transduced with retroviral vector expressing Her-2/neu. A. Autologous BLCL and BLCL-HM were stained with PE-conjugated anti-Her-2/neu antibody. Binding of anti-Her-2/neu Ab was analyzed by flow cytometry. BLCL is shown as a filled area, and BLCL-HM is shown as a solid line. B. BLCL #1 was stained with FITC-conjugated anti-human CD20 antibody. CD20 expression is shown as a solid line. Binding of the control antibody is shown as a filled area. C. BLCL #1 was stained with PE-conjugated anti-human MHC I antibody. The level of MHC I is shown as a solid line. Binding of the control antibody is shown as a filled area. Data are representative of at least three separate experiments.

More Related